Alan Jasmin
Impact in
- Immunology top 5%
- Immune Response and Inflammation
- interferon and immune responses
- Cancer Research top 5%
- NF-κB Signaling Pathways
Papers in
-
- Cell death mechanisms and regulation 4
- Inflammasome and immune disorders 2
- Bioactive Natural Diterpenoids Research 1
-
- interferon and immune responses 3
- Immune Response and Inflammation 3
- Co-authors
- Michael Eby (9 shared papers)Preet M. Chaudhary (9 shared papers)Leroy Hood (6 shared papers)Arvind Kumar (4 shared papers)Li Liu (1 shared paper)Suwan K. Sinha (1 shared paper)Barbara J. Trask (2 shared papers)Camari Ferguson (2 shared papers)
- Journals
- Oncogene (3 papers)Journal of Biological Chemistry (3 papers)Blood (2 papers)Immunity (1 paper)
- Partner nations
- United States
In The Last Decade
Alan Jasmin
9 papers receiving 1.6k citations
Alan Jasmin's Hit Papers
Peers
Comparison fields: 5 of 90
- Immunology 730
- Cancer Research 484
- Molecular Biology 986
- Oncology 348
- Microbiology 62
Countries citing papers authored by Alan Jasmin
This map shows the geographic impact of Alan Jasmin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Jasmin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Jasmin more than expected).
Fields of papers citing papers by Alan Jasmin
This network shows the impact of papers produced by Alan Jasmin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Jasmin. The network helps show where Alan Jasmin may publish in the future.
Co-authors
The 12 scholars most cited alongside Alan Jasmin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Death Receptor 5, a New Member of the TNFR Family, and DR4 Induce FADD-Dependent Apoptosis and Activate the NF-κB Pathway Hit paper breakdown → | 1997 | 603 |
| 2 | 1999 | 250 | |
| 3 | 2000 | 209 | |
| 4 | 1998 | 188 | |
| 5 | 2001 | 138 | |
| 6 | 2000 | 103 | |
| 7 | 1999 | 50 | |
| 8 | 1998 | 30 | |
| 9 | 2001 | 21 |
About Alan Jasmin
Alan Jasmin is a scholar working on Molecular Biology, Immunology, Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 9 papers that have together received 1.6k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (6 papers), Cell death mechanisms and regulation (4 papers), interferon and immune responses (3 papers), Immune Response and Inflammation (3 papers), Inflammasome and immune disorders (2 papers), Bioactive Natural Diterpenoids Research (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper) and Herpesvirus Infections and Treatments (1 paper). The work is most often cited by research in Immunology (730 citations), Cancer Research (484 citations), Molecular Biology (986 citations), Oncology (348 citations) and Microbiology (62 citations). Alan Jasmin has collaborated with scholars based in United States. Frequent co-authors include Michael Eby, Preet M. Chaudhary, Leroy Hood, Arvind Kumar, Li Liu, Suwan K. Sinha, Barbara J. Trask, Camari Ferguson, Oanh T. P. Nguyen and Hillary F. Massa. Their work appears in journals such as Oncogene, Journal of Biological Chemistry, Blood and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.